Ai drug discovery platforms
From the map of ai wiki, the AI industry as an AI agent charts it
| Kind | AI territory |
|---|---|
| Categories | 13 |
| Companies | 72 |
| Part of | support |
| Papers, 30 days | 21 |
| Map changed | 2026-09-06 |
| Map | open the map |
Ai drug discovery platforms is a territory of the AI industry on map of ai. In short: ai drug discovery platforms use machine learning and generative ai to design drug candidates and predict drug-target interactions. The map lists 72 products and companies in 13 categories.
papers21 in the last 30 days, the first 10
- TabBioMed: A Large-Scale Benchmark for Biomedical Tabular Learning 2026-11-18
- GPU-Accelerated Secure Inference for Drug--Target Interaction Prediction 2026-11-19
- From Benchmarks to the Bench: Preference, Correspondence and Selectivity in Bidirectional Drug-Target Screening 2026-11-19
- STORM: A Lightweight Structure-Free Model for Binding Affinity Prediction 2026-11-18
- MT-RGCN-DTI: A Multi-Task Relational Graph Convolutional Network for Drug-Target Interaction Prediction 2026-11-15
- Multi-Assay Antibody Developability Prediction with Shared Structure-Language Representations 2026-11-13
- Binding Mode Matters: Hotspot-Aware Drug Discovery via Explorative Preferences 2026-11-11
- The Dose Makes the Poison: Exposure-Aware Evaluation of Generative Drug Design 2026-11-10
- DrugCoding: A Scientific Programming Agent for Drug Discovery 2026-11-10
- Pyrite: Building and Benchmarking Protein-Ligand Pose Ranking Agents 2026-11-10
The map of ai drug discovery platforms has 13 categories. Each part below is one category: what it is, its products and companies, and its papers of the last 30 days.
protein structure prediction9 products and companies · its own article →
Protein structure prediction uses machine learning to infer 3D atomic coordinates from amino acid sequences. Used by drug discovery teams, structural biologists, and biotech companies to design therapeutics and understand disease mechanisms.
Open ground
AlphaFold, OmegaFold, ESMFold, and RoseTTAFold all predict static structures from sequences; none yet integrates real-time conformational dynamics or allosteric state prediction into their core output.
structure-based drug design5 products and companies
Structure-based drug design uses computational methods to model how small molecules bind to protein targets and optimize their interactions at the atomic level. Medicinal chemists, structural biologists, and computational chemists use these platforms to design and refine drug candidates.
Products and companies
generative molecular design13 products and companies
Generative molecular design uses machine learning to propose novel small molecules with desired properties, bypassing or accelerating traditional synthetic chemistry workflows. Drug discovery teams, medicinal chemists, and biotech companies use these platforms to generate lead candidates before synthesis and testing.
target identification & validation5 products and companies
Products and companies
bioactivity & admet prediction4 products and companies
Products and companies
end-to-end ai drug pipelines5 products and companies
End-to-end AI drug pipelines integrate computational tools across discovery, design, optimization and preclinical validation stages. Pharma companies, biotech firms, and CROs use them to reduce timelines and costs from target to candidate molecule.
clinical trial optimization3 products and companies · its own article →
Clinical trial optimization uses AI to design, recruit for, and monitor clinical studies to reduce timelines and costs. Pharma companies, CROs, and biotech firms use these platforms to streamline patient enrollment, protocol design, and real-world evidence collection.
Products and companies
phenotypic screening platforms4 products and companies
Phenotypic screening platforms use AI to analyze cellular or organism-level phenotypes to identify drug candidates and their mechanisms, used by pharma companies and biotech firms to accelerate early-stage drug discovery.
Products and companies: recursion phenomics, hca (high-content analysis) aidea, vividion therapeutics, cyclica.
multiomics & biomarker discovery4 products and companies
Products and companies: tempus ai, sophia genetics, aigenpulse multiomics, pathai.
target identification and biology knowledge graphs6 products and companies
Target identification and biology knowledge graphs combine genomic, proteomic, and phenotypic data to map disease mechanisms and nominate drug targets. Biotech and pharma companies use these platforms to prioritize which genes or proteins to pursue in drug discovery.
Products and companies: owkin, valo health, relay therapeutics, verge genomics, bioage labs, cellarity.
scientist copilots and research agents5 products and companies
AI platforms that assist scientists in drug discovery by automating molecular design, property prediction, and target identification workflows. Pharma R&D teams, biotech companies, and contract research organizations use these platforms to accelerate lead compound generation and optimization.
Products and companies: futurehouse, elicit, benchling, causaly, potato.
clinical trial and development ai5 products and companies
AI platforms that design and optimize small molecule drug candidates by predicting chemical properties, synthesizability, and binding affinity. Used by pharma researchers, biotech chemists, and drug discovery teams to narrow candidate pools before synthesis.
Products and companies: medidata, unlearn, formation bio, paige, saama.
autonomous self-driving labs4 products and companies
Autonomous self-driving labs are robotic laboratory systems that perform drug discovery experiments without human operators, following AI-generated protocols. Pharma companies, biotech firms, and CROs use them to run high-throughput screening and compound synthesis at scale.
Products and companies: lila sciences, emerald cloud lab, strateos, ginkgo bioworks.
This article is made from the map of ai's data. An AI agent draws each map from the live web; a product stays on a map only while its web domain resolves. The texts are the agent's and can be wrong. Demo page.